| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Sep―04 |
Methotrexate prolonged the shedding of replicable SARS-CoV-2 with re-increased antigens in a rheumatoid arthritis patient |
A Takatani, T Kobayashi, N Iwamoto, T Aramaki, K Terada, K Izumikawa, et al. (+5) MM Ngwe Tun, K Morita, Y Ueki, A Kawakami, K Eguchi |
| 2 |
[GO] |
2024―Feb―26 |
New onset of guttate psoriasis, Hallopeau’s continuous acrodermatitis, and psoriatic arthritis after COVID-19 vaccine |
A Zoli, G Peluso, M Grimaldi, C De Simone, MA D’Agostino, A Ortolan |
| 3 |
[GO] |
2024―Jan―10 |
When treatment takes a turn: tocilizumab-induced bowel perforation in a patient with COVID-19-afflicted rheumatoid arthritis |
W-H Yoo, GW Ha, KM Kim, Y Choi |
| 4 |
[GO] |
2023―Aug―22 |
A rare encounter: Kikuchi-Fujimoto disease presenting atypically after BNT162b2 COVID-19 vaccination: a case report |
K-H Nam, Y Choi |
| 5 |
[GO] |
2023―Jan―12 |
SARS-CoV-2 test patterns in Danish patients with inflammatory rheumatic diseases during the COVID-19 pandemic |
AHA Alzubaidi, R Cordtz, R Westermann, BG Soussi, KB Lauridsen, S Kristensen, L Dreyer |
| 6 |
[GO] |
2023―Jan―11 |
Scleroderma kidney disease exacerbated by COVID-19 vaccination |
T Horino |
| 7 |
[GO] |
2022―Sep―20 |
Risks and treatment related aspects of COVID-19 infection in patients with ANCA-associated vasculitis |
A Antovic, A Bruchfeld, J Ekland, B Lövström, A Hugelius, O Börjesson, et al. (+2) A Knight, I Gunnarsson |
| 8 |
[GO] |
2022―Aug―10 |
Diffuse systemic sclerosis following COVID-19 infection |
FR Blum, AJ Sampath, AL Gilbert, GT Foulke |
| 9 |
[GO] |
2022―Jul―20 |
Comment on “Humoral and cellular response to a third booster dose SARS-CoV- 2 vaccination in patients with autoimmune disease: a case series” |
T Dimitroulas, A Tychala, L Skoura |
| 10 |
[GO] |
2022―Jul―14 |
Presence of SARS-CoV-2 antibodies in patients with COVID-19 like symptoms from the IENIMINI cohort |
L van Ouwerkerk, D van der Woude, T Rispens, CF Allaart, TWJ Huizinga |
| 11 |
[GO] |
2022―Jul―14 |
Third booster dose SARS-CoV- 2 vaccination in patients with autoimmune disease: correspondence |
P Sookaromdee, V Wiwanitkit |
| 12 |
[GO] |
2022―Jun―06 |
Self-limiting reactive disease mimicking polymyalgia rheumatica following Moderna COVID-19 vaccine |
AW Nielsen, IT Hansen, LC Gormsen, E-M Hauge, KK Keller |
| 13 |
[GO] |
2022―May―31 |
Immunogenicity of the mRNA-1273 and ChAdOx1 nCoV-19 vaccines in Asian patients with autoimmune rheumatic diseases under biologic and/or conventional immunosuppressant treatments |
H-T Liao, H-Y Tung, C-T Chou, H-C Tsai, Y-N Yen, C-Y Tsai |
| 14 |
[GO] |
2022―May―12 |
Risk of severe COVID-19 in patients with inflammatory rheumatic diseases treated with immunosuppressive therapy in Scotland |
PM McKeigue, D Porter, RJ Hollick, SH Ralston, DA McAllister, HM Colhoun |
| 15 |
[GO] |
2022―May―12 |
Humoral and cellular response to a third booster dose SARS-CoV- 2 vaccination in patients with autoimmune disease: a case series |
T Dimitroulas, A Tychala, E Katsimpourlia, E Sidiropoulou, K Deuteraiou, M Papachristou, et al. (+2) A Fylaktou, L Skoura |
| 16 |
[GO] |
2022―Feb―09 |
Anti-synthetase syndrome occurring after SARS-CoV-2 infection |
M Bouchard Marmen, B Ellezam, MJ Fritzler, Y Troyanov, PV Gould, M Satoh, et al. (+3) A Meyer, Z Mahjoub, O Landon-Cardinal |
| 17 |
[GO] |
2021―Nov―17 |
COVID-19 vaccination and large-vessel giant cell arteritis |
R Mungmungpuntipantip, V Wiwanitkit |
| 18 |
[GO] |
2021―Sep―28 |
Large-vessel giant cell arteritis after COVID-19 vaccine |
A Mejren, CM Sørensen, LC Gormsen, RS Tougaard, BD Nielsen |
| 19 |
[GO] |
2021―Jul―07 |
Severe acute respiratory syndrome coronavirus-2-induced flare of systemic sclerosis |
C Campochiaro, G De Luca, N Farina, D Vignale, A Palmisano, M Matucci-Cerinic, L Dagna |
| 20 |
[GO] |
2021―Jun―25 |
Systemic Capillary Leak Syndrome triggered by SARS-CoV2 infection: Case Report and Systematic Review |
A Beber, F Dellai, M Abdel Jaber, D Peterlana, G Brunori, A Maino |
| 21 |
[GO] |
2021―Feb―05 |
Resilience of systemic sclerosis patients following the first COVID-19 wave in Italy |
J Ciaffi, D Giuggioli, A Spinella, R Meliconi, F Ursini, C Ferri |
| 22 |
[GO] |
2020―Sep―11 |
Biomarker-guided application of low-dose anakinra in an acute respiratory distress syndrome patient with severe COVID-19 and cytokine release syndrome |
MJ Steinhardt, S Wiebecke, D Weismann, S Frantz, HP Tony, H Klinker, M Schmalzing |
| 23 |
[GO] |
2020―Aug―28 |
Impact of the COVID-19 outbreak on an Italian cohort of systemic sclerosis patients |
M Bellan, S Parisi, P Stobbione, AR Pedrinelli, E Rizzi, GF Casciaro, et al. (+14) V Vassia, R Landi, MG Cittone, C Rigamonti, F Patrucco, MC Ditto, A Finucci, C Realmuto, M Todoerti, M Parodi, P Rossi, M Pirisi, E Fusaro, PP Sainaghi |
| 24 |
[GO] |
2020―Jul―28 |
Is there really room for anti-rheumatic drugs in the treatment of COVID-19? |
EG Favalli, F Ingegnoli, M Biggioggero, R Caporali |
